Beste apotheek van Nederland

Chen J, Godschalk M F, Katz P G et al. Incidence of penile pain
after injection of a new formulation of prostaglandin E1.[see
comment]. Br J Urol 1995;154(1):77-79.
Chen J, Godschalk M F, Katz P G et al. Combining
intracavernous injection and external vacuum as treatment for
erectile dysfunction.[see comment]. Br J Urol
1995;153(5):1476-1477.
Cooper A J. Evaluation of I-C papaverine in patients with
psychogenic and organic impotence. Canadian Journal of
Psychiatry - Revue Canadienne de Psychiatrie 1991;36(8):574­
578.
Dhabuwala C B, Kerkar P, Bhutwala A et al. Intracavernous
papaverine in the management of psychogenic impotence. Arch
Androl 1990;24(2):185-191.
Fedele D, Coscelli C, Cucinotta D et al. Management of erectile
dysfunction in diabetic subjects: results from a survey of 400
diabetes centres in Italy. Diabetes, Nutrition & Metabolism -
Clinical & Experimental 2001;14(5):277-282.
Fein R L. Classification of sexual dysfunction for management
of intracavernous medication-induced erections.[see comment].
Br J Urol 1990;143(2):298-301.
Fugl-Meyer A R, Lodnert G, Branholm I B et al. On life
satisfaction in male erectile dysfunction. Int J Impot Res
1997;9(3):141-148.
Godschalk M, Gheorghiu D, Chen J et al. Long-term efficacy of
a new formulation of prostaglandin E1 as treatment for erectile
failure.. Br J Urol 1996;155(3):915-917.
Govier F E, McClure R D, Weissman R M et al. Experience
with triple-drug therapy in a pharmacological erection
program.[see comment]. Br J Urol 1993;150(6):1822-1824.
Incrocci L, Hop W C, Slob A K. Visual erotic and vibrotactile
stimulation and intracavernous injection in screening men with
erectile dysfunction: a 3 year experience with 406 cases. Int J
Impot Res 1996;8(4):227-232.
Irwin M B, Kata E J. High attrition rate with intracavernous
injection of prostaglandin E1 for impotency. Urology
1994;43(1):84-87.
Jiann B-P, Yu C-C, Su C-C. Impact of introduction of sildenafil
on other treatment modalities for erectile dysfunction: A study
of nationwide and local hospital sales. Int J Impot Res
2004;16(6):527-530.
Kattan S A. The acceptance of satisfaction of Saudi males to
vasoactive autoinjection intracavernous therapy, external
negative pressure device and penile prosthesis in the treatment
of erectile dysfunction. Ann Saudi Med 2002;22(3-4):149-152.
Knispel H H, Huland H. Influence of cause on choice of therapy
in 174 patients with erectile dysfunction. Br J Urol
1992;147(5):1274-1276.
Lim P H, Ng F C. Erectile dysfunction in Singapore
men: presentation, diagnosis, treatment and results.
Ann Acad Med Singapore 1992;21(2):248-253.
Lottman P E, Hendriks J C, Vruggink P A et al. The
impact of marital satisfaction and psychological
counselling on the outcome of ICI-treatment in men
with ED. Int J Impot Res 1998;10(2):83-87.
Lundberg L, Olsson J-O, Kihl B. Long-term
experience of self-injection therapy with prostaglandin
E1 for erectile dysfunction. Scand J Urol Nephrol
1996;30(5):395-397.
Maniam P, Seftel A D, Corty E W et al. Nocturnal
penile tumescence activity unchanged after long-term
intracavernous injection therapy. Br J Urol
2001;165(3):830-832.
Mark S D, Keane T E, Vandemark R M et al.
Impotence following pelvic fracture urethral injury:
incidence, aetiology and management. Br J Urol
1995;75(1):62-64.
Montorsi F, Guazzoni G, Bergamaschi F et al.
Effectiveness and safety of multidrug intracavernous
therapy for vasculogenic impotence. Urology
1993;42(5):554-558.
Montorsi F, Guazzoni G, Bergamaschi F et al. Fourdrug
intracavernous therapy for impotence due to
corporeal veno-occlusive dysfunction. Br J Urol
1993;149(5 Pt 2):1291-1295.
Montorsi F, Guazzoni G, Bergamaschi F et al.
Intracavernous vasoactive pharmacotherapy: the
impact of a new self-injection device.[see comment].
Br J Urol 1993;150(6):1829-1832.
Mulhall J P, Jahoda A E, Cairney M et al. The causes
of patient dropout from penile self-injection therapy
for impotence. Br J Urol 1999;162(4):1291-1294.
Mulhall J P, Land S, Parker M et al. The use of an
erectogenic pharmacotheraphy regimen following
radical prostatectomy improves recovery of
spontaneous erectile function. Br J Sex Med
2005;2(4):532-542.
Perimenis P, Athanasopoulos A, Geramoutsos I et al.
The incidence of pharmacologically induced priapism
in the diagnostic and therapeutic management of 685
men with erectile dysfunction. Urol Int 2001;66(1):27­
29.
Rowland D L, Boedhoe H S M, Dohle G et al.
Intracavernosal self-injection therapy in men with
erectile dysfunction: Satisfaction and attrition in 119
patients. Int J Impot Res 1999;11(3):145-151.
D-89